Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

CHRISTOPHER U REX

Allopathic & Osteopathic Physicians Dermatology

NPI
1083054571
CMS profile
451075
Location
PAYSON, AZ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$10,029.59

112 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

By paying entity

PY2022 · entire year · sorted by reported total

Page 2 of 3; records 51–100 of 112 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

CHRISTOPHER U REX

NPI 1083054571 · CMS profile ID 451075

Allopathic & Osteopathic Physicians / Dermatology

PAYSON, AZ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 112 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1083054571?year=2022&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
CHRISTOPHER U REX, NPI 1083054571, CMS profile ID 451075. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 112 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1083054571?year=2022&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). CHRISTOPHER U REX, NPI 1083054571, CMS profile ID 451075. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 112 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1083054571?year=2022&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
CHRISTOPHER U REX, NPI 1083054571, CMS profile ID 451075, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 112 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1083054571?year=2022&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

112 matching records · $10,029.59 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 112 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 112.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Paratek Pharmaceuticals, Inc. $17.7606/14/2022 Food and Beverage No dispute reported Delay: No
Change: CHANGED
06/30/2026 881685025 CMS
Allergan, Inc. $28.0006/01/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 889968897 CMS
Amgen Inc. $17.4405/31/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939840105 CMS
Amgen Inc. $18.8605/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939840103 CMS
UCB, Inc. $34.0805/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 908005761 CMS
ABBVIE INC. $29.8305/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891443191 CMS
Nabriva Therapeutics, plc $12.0805/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 961086145 CMS
Sun Pharmaceutical Industries Inc. $11.5505/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 947747427 CMS
Janssen Biotech, Inc. $89.9905/19/2022 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885509511 CMS
Paratek Pharmaceuticals, Inc. $16.8305/17/2022 Food and Beverage No dispute reported Delay: No
Change: CHANGED
06/30/2026 881685019 CMS
Janssen Biotech, Inc. $12.6705/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885509515 CMS
GENZYME CORPORATION $23.5405/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939055691 CMS
Ortho Dermatologics, a division of Bausch Health US, LLC $14.3805/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 947501379 CMS
PFIZER INC. $18.5905/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949619963 CMS
Almirall LLC $18.3805/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 902854841 CMS
Ortho Dermatologics, a division of Bausch Health US, LLC $8.6305/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 947501377 CMS
GENZYME CORPORATION $21.3704/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939055687 CMS
Amgen Inc. $18.4904/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939840101 CMS
GENZYME CORPORATION $23.9304/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939055685 CMS
ABBVIE INC. $1,350.0004/22/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891443189 CMS
Lilly USA, LLC $16.4104/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 917950137 CMS
ABBVIE INC. $23.3604/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891443187 CMS
Lilly USA, LLC $12.7304/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 917952189 CMS
Lilly USA, LLC $11.5104/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 917950135 CMS
Amgen Inc. $17.1804/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939840109 CMS
Merz North America, Inc. $119.6504/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 950333063 CMS
Sun Pharmaceutical Industries Inc. $22.3404/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 947747451 CMS
UCB, Inc. $18.9504/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 908049563 CMS
Biofrontera Inc. $8.8704/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 928731863 CMS
Ortho Dermatologics, a division of Bausch Health US, LLC $14.4203/30/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 947501373 CMS
Ortho Dermatologics, a division of Bausch Health US, LLC $16.6003/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 947501375 CMS
ABBVIE INC. $91.7803/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891443185 CMS
PFIZER INC. $20.4103/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949632343 CMS
Allergan, Inc. $21.0403/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 889968895 CMS
Sun Pharmaceutical Industries Inc. $27.1603/10/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 947747443 CMS
Amgen Inc. $18.3103/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939840107 CMS
UCB, Inc. $23.2703/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 908049567 CMS
Sun Pharmaceutical Industries Inc. $25.5303/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 947747447 CMS
ABBVIE INC. $28.7103/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891443183 CMS
Incyte Corporation $21.9403/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 943067989 CMS
Merz North America, Inc. $400.0003/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 950333061 CMS
ABBVIE INC. $7.6402/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891443181 CMS
Biofrontera Inc. $12.3302/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915202873 CMS
UCB, Inc. $12.1602/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 908049559 CMS
Amgen Inc. $18.5802/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939840099 CMS
Lilly USA, LLC $12.2102/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 917953021 CMS
ABBVIE INC. $23.9702/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891443179 CMS
PFIZER INC. $6.6802/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949417817 CMS
Incyte Corporation $21.9402/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 943067973 CMS
Sun Pharmaceutical Industries Inc. $18.3302/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 947747439 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,822.99 77
PY2020 $2,059.66 90
PY2021 $2,953.88 101
PY2022 $10,029.59 112
PY2023 $10,674.27 64
PY2024 $1,285.02 59
PY2025 $1,776.05 50

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Recipient $1,507.18 8
PY2025 Principal investigator $12,238.28 3

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

11 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ABBVIE INC. $75.00 10/09/2025 Non-covered Recipient Entity
PEAK DERMATOLOGY AESTHETICS AND WELLNESS FOUNTAIN HILLS
A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy (Step-Up HS) No dispute reported 06/30/2026 1202516361
Principal investigator 1 Novartis Pharmaceuticals Corporation $370.28 10/01/2025 Non-covered Recipient Entity
PEAK DERMATOLOGY
A US Phase 3b, Multi-center, Randomized, Double-blind, Double-Dummy Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-Antihista No dispute reported 06/30/2026 1190312635
Recipient Regeneron Pharmaceuticals, Inc. $292.99 08/29/2025 Covered Recipient Physician A Phase 3 Randomized Study of Intralesional Cemiplimab Versus Primary Surgery in Participants With Early Stage Cutaneous Squamous Cell Carcinoma (CSCC) No dispute reported 06/30/2026 1184121699
Recipient Regeneron Pharmaceuticals, Inc. $196.67 08/29/2025 Covered Recipient Physician A Phase 3 Randomized Study of Intralesional Cemiplimab Versus Primary Surgery in Participants With Early Stage Cutaneous Squamous Cell Carcinoma (CSCC) No dispute reported 06/30/2026 1184121701
Recipient Regeneron Pharmaceuticals, Inc. $60.13 08/29/2025 Covered Recipient Physician A Phase 3 Randomized Study of Intralesional Cemiplimab Versus Primary Surgery in Participants With Early Stage Cutaneous Squamous Cell Carcinoma (CSCC) No dispute reported 06/30/2026 1184121703
Recipient Regeneron Pharmaceuticals, Inc. $26.73 08/29/2025 Covered Recipient Physician A Phase 3 Randomized Study of Intralesional Cemiplimab Versus Primary Surgery in Participants With Early Stage Cutaneous Squamous Cell Carcinoma (CSCC) No dispute reported 06/30/2026 1184121705
Recipient Regeneron Pharmaceuticals, Inc. $73.50 08/29/2025 Covered Recipient Physician A Phase 3 Randomized Study of Intralesional Cemiplimab Versus Primary Surgery in Participants With Early Stage Cutaneous Squamous Cell Carcinoma (CSCC) No dispute reported 06/30/2026 1184121707
Recipient Regeneron Pharmaceuticals, Inc. $2.34 08/29/2025 Covered Recipient Physician A Phase 3 Randomized Study of Intralesional Cemiplimab Versus Primary Surgery in Participants With Early Stage Cutaneous Squamous Cell Carcinoma (CSCC) No dispute reported 06/30/2026 1184121709
Recipient Regeneron Pharmaceuticals, Inc. $49.44 08/29/2025 Covered Recipient Physician A Phase 3 Randomized Study of Intralesional Cemiplimab Versus Primary Surgery in Participants With Early Stage Cutaneous Squamous Cell Carcinoma (CSCC) No dispute reported 06/30/2026 1184121711
Recipient Regeneron Pharmaceuticals, Inc. $805.38 08/08/2025 Covered Recipient Physician A Phase 3 Randomized Study of Intralesional Cemiplimab Versus Primary Surgery in Participants With Early Stage Cutaneous Squamous Cell Carcinoma (CSCC) No dispute reported 06/30/2026 1184121697
Principal investigator 1 ABBVIE INC. $11,793.00 08/06/2025 Non-covered Recipient Entity
PEAK DERMATOLOGY AESTHETICS AND WELLNESS FOUNTAIN HILLS
A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy (Step-Up HS) No dispute reported 06/30/2026 1202502977